CRYMACHINA
FURYU Corporation · 2023 · $59.99 · Action · deal grade A
- Estimated net residual revenue: $3.4k to $5.1k per month
- Opportunity: $8.1k per month at x1.90 dormancy
- Estimated lifetime owners: 23.1k
- 86%% positive across 768 reviews · 11.3 reviews/month
Why it's flagged
- Developer silent for 2.2 years
- Studio active elsewhere (11 titles tracked), so this one may welcome a partner
- Last build shipped 26 months ago
- Store page localized in only 4 language(s)
- Last discounted 1 months ago, 5 sales in the last 12 months
- Proven demand elasticity: x1.3 review velocity during past deep sales
Analyst notes (AI-assisted)
Sci-fi anime action game with real-time combat, story-driven narrative, and a dynamic soundtrack by Sakuzyo, developed by FURYU as a spiritual successor to Crystar.
CRYMACHINA sits in a narrow but passionate niche: 86% positive reviews and $4,238/mo residual revenue with minimal developer engagement suggest a cult title with strong attach among anime-action players who value narrative over mechanics. The $345k lifetime net on ~23k units indicates price sensitivity (elasticity 1.3) and a localization gap (43% to Simplified Chinese) that could unlock dormant demand. Acquisition is viable for Japanese-focused publishers seeking IP with existing community goodwill and expansion runway; revival via regional pricing and promotional bundling is the faster play. Most realistic play: revival.
- Risk: Player consensus flags gameplay as secondary to story and soundtrack; mechanical depth may limit appeal beyond core anime-action demographic and poses ceiling on mainstream conversion.
- Risk: Pricing ($59.99) cited repeatedly by buyers as misaligned with perceived value; elasticity 1.3 suggests significant upside in promotional discounting, but full-price sell-through remains weak.
- Risk: 2023 release with 2+ years no developer communication and minimal post-launch support suggests limited appetite for live-service or ongoing content.
This case as Markdown · Estimates carry ±30-50%% error per title.